National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 284895

Case Details

VAERS ID: 284895 (history)  
Age: 24.0  
Gender: Female  
Location: Unknown  
Vaccinated:2006-11-08
Onset:2007-03-23
   Days after vaccination:135
Submitted: 2007-07-06
   Days after onset:105
Entered: 2007-07-13
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Drug exposure during pregnancy, Metrorrhagia, Nausea, Pregnancy, Ultrasound abdomen
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Pregnancy NOS (LMP = 2/27/2007)
Preexisting Conditions:
Diagnostic Lab Data: Ultrasound 03/26/07 - "early IOP"
CDC Split Type: WAES0705USA00321

Write-up: Initial and follow up information has been received for a Merck Pregnancy Registry via a health professional concerning a female who on 06-SEP-2006 was vaccinated with the first dose of Gardasil (lot not reported). On 08-NOV-2006, the patient was vaccinated with the second dose of Gardasil (lot reported as "9725101"). The patient was found to be pregnant after receiving her second dose, and it was noted as "second trimester". Routine vital signs were noted to be performed. The patient sought unspecified medical attention. Additional information has been received concerning the 24 year old female who had her last menstrual period on 27-FEB-2007 (estimated date of delivery, 04-NOV-2007). From 23-MAR-2007 to 03-MAY-2007 the patient was treated with PROMETRIUM, 200 mg BID, for low progesterone. From 23-MAR-2007 to the present she was treated with PHENERGAN, 25 mg PRN for nausea. On 26-MAR-2007 an ultrasound was performed due to "spotting". The results of test were "Early IOP". Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=284895


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166